According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.37 Billion a decrease over its 2022 earnings that were of -S$7.33 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$0.36 Billion | -0.71% |
2023 | -S$0.37 Billion | 4848.63% |
2022 | -S$7.33 Million | -93.25% |
2021 | -S$0.11 Billion | 2.52% |
2020 | -S$0.11 Billion | -69.45% |
2019 | -S$0.35 Billion | -700.62% |
2018 | S$57.62 M | -118.02% |
2017 | -S$0.32 Billion | 805.99% |
2016 | -S$35.31 Million | -173.88% |
2015 | S$47.78 M | -6.58% |
2014 | S$51.14 M | 20.19% |
2013 | S$42.55 M | 18.7% |
2012 | S$35.85 M | -26.54% |
2011 | S$48.8 M | |
2009 | -S$0.12 Billion | 10.65% |
2008 | -S$0.11 Billion | 86.17% |
2007 | -S$54.1 Million | 68.1% |
2006 | -S$32.19 Million |